Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities: 2016-2024

Historic Other Non-Current Liabilities for Collegium Pharmaceutical (COLL) over the last 3 years, with Dec 2024 value amounting to $1.2 million.

  • Collegium Pharmaceutical's Other Non-Current Liabilities fell 99.54% to $19,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19,000, marking a year-over-year decrease of 99.54%. This contributed to the annual value of $1.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Other Non-Current Liabilities is $1.2 million, which was up 74.85% from $676,000 recorded in FY2018.
  • Over the past 5 years, Collegium Pharmaceutical's Other Non-Current Liabilities peaked at $1.2 million during FY2024, and registered a low of $1.2 million during FY2024.
  • Moreover, its 1-year median value for Other Non-Current Liabilities was $1.2 million (2024), whereas its average is $1.2 million.